Developing Naturally Derived Psychedelic Medicines with Benjamin Lightburn Filament Health

Benjamin Lightburn, Co-Founder and CEO of Filament Health points out that up until now, research with psychedelics has been done with synthetically prepared psychedelic substances.  Filament is making a product through natural extraction that results in a medicine containing psilocybin plus over a dozen other active compounds from the magic mushrooms. This natural process does not require any toxic chemicals and can be distributed through non-medical distribution channels to treat a variety of mental health indications. Benjamin explains, "The psychedelics that have been showing a lot of promise recently in modern well-controlled clinical trials are being used for various mental health indications. Depression and PTSD are the ones that are most clinically advanced. But there's lots of very promising research in other areas, such as anxiety, substance use disorders, in particular alcohol use disorder, as well as in the areas of chronic pain, phantom limb pain, fibromyalgia, and things like that. Again, the list of indications for which psychedelic compounds can potentially be efficacious is still not yet known, and it is growing all the time as more research comes out." "Psychedelic medicine is always combined with therapy, so it's referred to as psychedelic-assisted psychotherapy. And this means that you'll typically visit a professional, like a psychiatrist, for a number of preparatory sessions before your psychedelic experience. And then, on the day of your psychedelic experience, you actually consume the drug. In our case, we produce oral capsules, which look just like any other capsule, but there are other routes of administration as well." @FilamentHealth #PsychedelicTherapy #NaturalMedicine #Psilocybin #Mushrooms #MagicMushrooms #Microdosing Filament.Health Download the transcript here